Switch to:
More From Other Websites
NeoStem to Present at the Swedish-American Life Science Summit 2014 Aug 20 2014
NEOSTEM, INC. Financials Aug 19 2014
NEOSTEM, INC. Files SEC form 8-K, Results of Operations and Financial Condition Aug 07 2014
NeoStem Announces Second Quarter 2014 Financial Results and Provides Business Update Aug 07 2014
NEOSTEM, INC. Files SEC form 10-Q, Quarterly Report Aug 07 2014
Increase Company Value Through Mergers, Acquisitions Jul 14 2014
NeoStem Awarded 2014 Cell Therapeutics Technology Leadership Award from Frost & Sullivan Jul 14 2014
NeoStem, Inc. – "Insider Buying" Jul 08 2014
RedChip Announces Schedule for Its July 16-17 Global Online CEO Conference Jul 08 2014
NEOSTEM, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Jul 08 2014
NeoStem Appoints Steven M. Klosk to Board of Directors Jul 08 2014
NeoStem's Cancer Immunotherapy Experts to Present at Novel Cancer Therapeutics Summit 2014 Jun 30 2014
NeoStem, Inc. "Cancer Treatment that Doesn't Make You Sick" Jun 25 2014
NeoStem Set to Join Multiple Russell Indexes Jun 23 2014
NeoStem presents results for Phase 1 study of autologous Treg immunotherapy Jun 16 2014
NeoStem Announces UCSF Presentation of Phase 1 Results for T Regulatory Cell Immunotherapy for Type... Jun 16 2014
NeoStem Clarification: No New Securities Being Issued Jun 12 2014
Aegis Capital Corp Reiterates Buy Rating of NeoStem, Inc. Jun 04 2014
NeoStem Announces Access to New $30 Million Equity Facility With Aspire Capital to Replace the Fully... Jun 03 2014
NEOSTEM, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 03 2014


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK